PLOS ONE, PLOS Medicine and PLOS Computational Biology welcomes submissions covering machine learning solutions to healthcare on all scales,
from precision medicine to outbreak monitoring.
Not exact matches
«It certainly appears that they are focused on
precision medicine,
from prevention to treatment.
Additionally, the agency would continue efforts to advance
precision medicine and cancer genomics in support of the Million Veteran Program (MVP), which aims to collect blood samples and health information
from one million veteran volunteers to study how genes affect health.
Matching unique genetic information
from cancer patients» tumors with treatment options — an emerging area of
precision medicine efforts — often fails to identify all patients who may respond to certain therapies.
In particular, he will focus on advancing
precision medicine; delivering data products that integrate and usefully present information
from multiple sources; and, ensuring that privacy and ethical concerns are taken into account in data science policy.
Patients treated with
precision medicine also benefited
from longer progression - free survival with a median of 5.7 months before their disease worsened compared to 2.95 months for the others.
R&D spending includes everything
from the Defense Advanced Research Project Agency's initiatives in the Defense Department relating to biosecurity and technological tracking devices, to the National Institutes of Health's projects relating to research into
precision medicine and advances in the understanding of the brain.
The emphasis now is to store samples
from almost every major study with correlative science in mind, and this is essential if we are to understand disease biology, mechanism of response and resistance to therapy in the era of targeted therapy and
precision medicine.»
Matthew J. Ellis, MD, PhD, said the research, presented at the San Antonio Breast Cancer Symposium, is a step toward
precision medicine, allowing scientists to study tumors
from patients whose treatment regimens are well - documented.
After poking fun at his own knowledge of science — a model of chromosomes made
from pink swim noodles «was helpful to me,» he said — Obama explained what
precision medicine is: «delivering the right treatments, at the right time, every time to the right person.»
Scientists and clinicians have increasingly tried to move away
from simplistic racial and ethnic categories in disease research, the authors say, and — with the rise of
precision medicine — in clinical diagnosis and treatment as well.
As part of the
precision medicine initiative at the Cancer Institute of New Jersey, investigators — which include colleagues
from Rutgers Robert Wood Johnson Medical School and RUCDR Infinite Biologics, the world's largest university - based biorepository, located within the Human Genetics Institute of New Jersey — wanted to define the relationship of ERBB2 alterations in the pleomorphic form of the disease.
«Having the power to read regulatory potential
from DNA sequences can contribute to using
precision medicine — prescribing certain drugs or treatments that would work specifically on that patient's cancer.»
«How will the innovations
from the President's initiative reach the doctor and the patient, and how will the new data types needed for
precision medicine be integrated into medical decision making?»
«This could be a game - changer in epilepsy diagnosis and could make
precision medicine part of standard clinical practice,» says lead author Anne T. Berg, PhD,
from Stanley Manne Children's Research Institute at Ann & Robert H. Lurie Children's Hospital of Chicago.
His work centers on developing general, rational approaches to design
precision medicines from genome sequences by targeting the RNA product of genes.
It should be noted that the 7th Pan Arab Human Genetics Conference will be held
from 18 to 20 January 2018 at Conrad hotel in Dubai, and will discuss the Omics Era through 4 main topics:
precision medicine, big data in human genetics, genomics of multifactorial disorders, and the current trend in human genetics sciences.
On Dec. 1 - 2, those issues will come to the fore as national experts in genetics,
medicine, law, big data and other fields gather for Frontiers in Precision Medicine II: Cancer, Big Data and the Public, a unique precision medicine symposium at the University of Utah S.J. Quinney College of Law, Center for Law and Biomedical Sciences, University of Utah Health Sciences, Huntsman Cancer Institute, and University of Utah Center for Excellence in ELSI Research (UCEER) addresses those topics as precision medicine is gaining more attention nationwide from health care systems, practitioners, researchers, insurers and federal a
medicine, law, big data and other fields gather for Frontiers in
Precision Medicine II: Cancer, Big Data and the Public, a unique precision medicine symposium at the University of Utah S.J. Quinney College of Law, Center for Law and Biomedical Sciences, University of Utah Health Sciences, Huntsman Cancer Institute, and University of Utah Center for Excellence in ELSI Research (UCEER) addresses those topics as precision medicine is gaining more attention nationwide from health care systems, practitioners, researchers, insurers and federal a
Medicine II: Cancer, Big Data and the Public, a unique
precision medicine symposium at the University of Utah S.J. Quinney College of Law, Center for Law and Biomedical Sciences, University of Utah Health Sciences, Huntsman Cancer Institute, and University of Utah Center for Excellence in ELSI Research (UCEER) addresses those topics as precision medicine is gaining more attention nationwide from health care systems, practitioners, researchers, insurers and federal a
medicine symposium at the University of Utah S.J. Quinney College of Law, Center for Law and Biomedical Sciences, University of Utah Health Sciences, Huntsman Cancer Institute, and University of Utah Center for Excellence in ELSI Research (UCEER) addresses those topics as
precision medicine is gaining more attention nationwide from health care systems, practitioners, researchers, insurers and federal a
medicine is gaining more attention nationwide
from health care systems, practitioners, researchers, insurers and federal agencies.
«This study is an important step towards developing
precision medicine for at - risk and understudied minority populations,» Burchard said, «But the current lack of genomic data
from these populations highlights the urgent need for a dedicated national effort to prioritize diversity in research.»
In their pursuit of cures for debilitating diseases, Gladstone scientists are approaching
precision medicine from new angles, researching the microbiome and protein networks that are critical for human biology.
She is currently pursuing projects in
precision medicine for analysis of transcriptome data
from patients with rare lung diseases (Sarcoidosis, Coccidiomycosis), and integrative network analysis of complex traits including Alzheimer's Disease.
Atul Butte, PhD, who is Priscilla Chan and Mark Zuckerberg Distinguished Professor at UCSF and directs the Institute for Computational Health Sciences, a hub for
precision medicine research on campus, echoed the excitement felt across UCSF about moving towards clinical application of
precision medicine: «
Precision medicine is not just a «nice idea» at UCSF — it is benefitting real people,
from cancer patients with unusual tumor mutations to children with undiagnosed genetic diseases.
From our earliest research that established cancer as a genetic disease to today's work in
precision medicine, our unswerving focus on genetics and genomics continues to generate advances that improve human health.
In this digital
precision medicine lab, students will order tests and examine clinical features of cancers
from patients, including gene expression in the cancer and appearance under the microscope, to advise on the best course of treatment
As in people,
precision medicine in dogs is a work in progress, but companies and veterinary schools already offer a variety of genetic tests for everything
from breed identification to inherited genetic disorders.
From enabling unprecedented transparency, to active progress in open government and open machine readable data, innovation funds that scale what works, new types of public - private partnerships, and
precision medicine, the Obama administration has made great strides to expand and prioritize innovation - driven policy.